RxDoctor Payments Data

Elisabeth Carpenter

Psychiatric/Mental Health · Bryn Mawr, PANPI 1285203968

Payments from drug & device makers

$2,586in general payments, 2019–2025

Across 128 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$400
  • AbbVie$393
  • Alkermes, Inc.$336
  • Johnson & Johnson$309
  • Teva Pharmaceuticals USA, Inc.$272
  • Corium, LLC$192
  • plus $685 from 7 others

What the payments were for

  • Food & beverage$2,52598%
  • Education$612%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,586 in reported general payments places this provider in the 80th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$21,382
Medicare patients
51
Services billed
236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl46$63,548
Invega SustennaPaliperidone Palmitate12$45,559
Lurasidone Hcl31$26,791
Fluphenazine Hcl13$3,660
Chlorpromazine Hcl14$3,361
Clozapine41$2,336
Quetiapine Fumarate148$2,264
Divalproex Sodium ErDivalproex Sodium47$1,813
Aripiprazole41$1,687
Bupropion XlBupropion Hcl63$1,410
Atomoxetine Hcl11$977
Quetiapine Fumarate ErQuetiapine Fumarate20$970
Duloxetine Hcl50$963
Lorazepam48$873
Lamotrigine101$814

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$393$63,54846 claims
Johnson & JohnsonInvega Sustenna$309$45,55912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Bryn Mawr

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →